Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice
Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. ESPGHAN 50th Annual Meeting, Prague, May 2017
Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements
Chadokufa S, Acton N, Sider S, Sheppard R, Wearon R, Shah N, Knaflez D, Kiparissi F. Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements. 4th Annual International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017
Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice
Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. 4th International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017
Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice
Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. 12th Congress of European Crohn’s and Colitis Organization, Barcelona, September 2017
Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool
Chadokufa S, Wearon R. Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool. 4th Annual International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017
Why and how adolescents and young adults with inflammatory bowel disease use cannabis
Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Why and how adolescents and young adults with inflammatory bowel disease use cannabis. NASPGHAN Annual Meeting, Las Vegas, November 2017